Home / Import refusals / 799-8328738-7/10002/1

FDA Import Refusal 799-8328738-7/10002/1 — Incepta Pharmaceuticals Ltd

Incepta Pharmaceuticals Ltd — FEI 3007306071

The FDA refused shipment 799-8328738-7/10002/1 from Incepta Pharmaceuticals Ltd (Bangladesh) on February 7, 2026. The refused product falls under Drugs and Biologics — SEMAGLUTIDE (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
February 7, 2026
Country
Bangladesh
Product Category
Drugs and Biologics
Product Code
61PCP72 SEMAGLUTIDE (ANTI-DIABETIC)
Charges
75

Other import refusals

  • AEK-0388727-9/20002/1 (Thu May 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-8328738-7/20002/1 (Sat Feb 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Human Foods)
  • AEK-9153923-7/20002/1 (Mon Jan 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-7675643-4/10002/1 (Tue Oct 07 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-7364558-0/12/1 (Wed Sep 24 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources